Disseminated intravascular coagulation epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
DIC is seen in approximately 1 percent of admissions to tertiary care hospitals. In a series of 123,231 patients admitted to university hospitals in Japan, 1286 were diagnosed with DIC (1 percent) [19]. These data may underestimate the incidence of mild, subclinical, or transient DIC. In contrast, the incidence of DIC may be lower in lower acuity settings.
The incidence of DIC in specific medical conditions is illustrated by the following examples:
●'''Cancer''' – DIC is seen in a significant number of patients with cancer. Malignancies most likely to cause DIC include acute promyelocytic leukemia, pancreatic cancer, and other mucin-producing solid tumors such as gastric, prostate, breast, and ovarian cancer [20]. In a cohort of 1117 patients with various solid tumor malignancies, DIC was diagnosed in 76 (6.8 percent) [21]. Significant risk factors for the development of DIC included age >60 years (odds ratio [OR] 5.1), male sex (OR 4.3), breast cancer (OR 4.0), tumor necrosis (OR 3.4), and advanced stage disease (OR 2.6).
●'''Infection''' – DIC is common in patients with bacterial sepsis, with increasing likelihood related to the severity of the systemic inflammatory response. In a series of 35 patients who met criteria for systemic inflammatory response syndrome for four or more consecutive days, DIC was seen in 29 (83 percent) [22]. (See "Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis".)
●'''Trauma''' – In a review of 136 patients with severe trauma, 42 had DIC (31 percent) [23]. Series of patients with head trauma have reported DIC in approximately 40 percent [24,25].
●'''Obstetrical complications''' – The incidence of DIC in patients with obstetrical complications ranges from 20 percent in patients with hemolysis, elevated liver function tests, and low platelets (HELLP syndrome) to 66 percent in patients with amniotic fluid embolism [26,27]. These and other obstetrical conditions associated with DIC are discussed in detail separately. (See "Disseminated intravascular coagulation during pregnancy".)


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence of [[DIC]] is different in different [[diseases]] as it is almost always related to a life threatening condition.
*The incidence of [[DIC]] is different in different [[diseases]] as it is almost always related to a life threatening condition. It depends on the cause of DIC such as cancer, infection, trauma and Obstetrical complications
*In 2010, the [[incidence]] of [[DIC]] was estimated to be 26.2 cases per 100,000 individuals worldwide.<ref name="pmid23139140">{{cite journal |vauthors=Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G |title=Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study |journal=Chest |volume=143 |issue=5 |pages=1235–1242 |date=May 2013 |pmid=23139140 |doi=10.1378/chest.12-2112 |url=}}</ref>
*In 2010, the [[incidence]] of [[DIC]] was estimated to be 26.2 cases per 100,000 individuals worldwide.<ref name="pmid23139140">{{cite journal |vauthors=Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G |title=Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study |journal=Chest |volume=143 |issue=5 |pages=1235–1242 |date=May 2013 |pmid=23139140 |doi=10.1378/chest.12-2112 |url=}}</ref>


===Prevalence===
===Prevalence===
*The prevalence of [[DIC]] depends on the clinical settings, higher versus low acquity settings.
*The prevalence of [[DIC]] depends on the clinical settings, higher versus low acquity settings.
*In [year], the incidence/prevalence of [disease name] was estimated to be 18.6 per 100,000 individuals worldwide.
*In 2013, the prevalence of DIC was estimated to be 46.8% (292/624) <ref name="pmid23787004">{{cite journal |vauthors=Gando S, Saitoh D, Ogura H, Fujishima S, Mayumi T, Araki T, Ikeda H, Kotani J, Kushimoto S, Miki Y, Shiraishi S, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, Aikawa N |title=A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis |journal=Crit Care |volume=17 |issue=3 |pages=R111 |date=June 2013 |pmid=23787004 |pmc=4056654 |doi=10.1186/cc12783 |url=}}</ref>
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===
Line 20: Line 30:


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*Patients of all age groups may develop DIC.
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
*There is no racial predilection to DIC
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
===Gender===
===Gender===
*[Disease name] affects men and women equally.
* DIC affects men and women equally
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
 
===Region===
*The majority of [disease name] cases are reported in [geographical region].
 
*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].


===Developing Countries===
===Developing Countries===

Revision as of 16:50, 27 August 2018

Disseminated intravascular coagulation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Disseminated intravascular coagulation from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Disseminated intravascular coagulation epidemiology and demographics On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Disseminated intravascular coagulation epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Disseminated intravascular coagulation epidemiology and demographics

CDC on Disseminated intravascular coagulation epidemiology and demographics

Disseminated intravascular coagulation epidemiology and demographics in the news

Blogs on Disseminated intravascular coagulation epidemiology and demographics

Directions to Hospitals Treating Disseminated intravascular coagulation

Risk calculators and risk factors for Disseminated intravascular coagulation epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]

Overview

DIC is seen in approximately 1 percent of admissions to tertiary care hospitals. In a series of 123,231 patients admitted to university hospitals in Japan, 1286 were diagnosed with DIC (1 percent) [19]. These data may underestimate the incidence of mild, subclinical, or transient DIC. In contrast, the incidence of DIC may be lower in lower acuity settings.

The incidence of DIC in specific medical conditions is illustrated by the following examples:

Cancer – DIC is seen in a significant number of patients with cancer. Malignancies most likely to cause DIC include acute promyelocytic leukemia, pancreatic cancer, and other mucin-producing solid tumors such as gastric, prostate, breast, and ovarian cancer [20]. In a cohort of 1117 patients with various solid tumor malignancies, DIC was diagnosed in 76 (6.8 percent) [21]. Significant risk factors for the development of DIC included age >60 years (odds ratio [OR] 5.1), male sex (OR 4.3), breast cancer (OR 4.0), tumor necrosis (OR 3.4), and advanced stage disease (OR 2.6).

Infection – DIC is common in patients with bacterial sepsis, with increasing likelihood related to the severity of the systemic inflammatory response. In a series of 35 patients who met criteria for systemic inflammatory response syndrome for four or more consecutive days, DIC was seen in 29 (83 percent) [22]. (See "Sepsis syndromes in adults: Epidemiology, definitions, clinical presentation, diagnosis, and prognosis".)

Trauma – In a review of 136 patients with severe trauma, 42 had DIC (31 percent) [23]. Series of patients with head trauma have reported DIC in approximately 40 percent [24,25].

Obstetrical complications – The incidence of DIC in patients with obstetrical complications ranges from 20 percent in patients with hemolysis, elevated liver function tests, and low platelets (HELLP syndrome) to 66 percent in patients with amniotic fluid embolism [26,27]. These and other obstetrical conditions associated with DIC are discussed in detail separately. (See "Disseminated intravascular coagulation during pregnancy".)

Epidemiology and Demographics

Incidence

  • The incidence of DIC is different in different diseases as it is almost always related to a life threatening condition. It depends on the cause of DIC such as cancer, infection, trauma and Obstetrical complications
  • In 2010, the incidence of DIC was estimated to be 26.2 cases per 100,000 individuals worldwide.[1]

Prevalence

  • The prevalence of DIC depends on the clinical settings, higher versus low acquity settings.
  • In 2013, the prevalence of DIC was estimated to be 46.8% (292/624) [2]

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Patients of all age groups may develop DIC.

Race

  • There is no racial predilection to DIC

Gender

  • DIC affects men and women equally

Developing Countries

References

  1. Singh B, Hanson AC, Alhurani R, Wang S, Herasevich V, Cartin-Ceba R, Kor DJ, Gangat N, Li G (May 2013). "Trends in the incidence and outcomes of disseminated intravascular coagulation in critically ill patients (2004-2010): a population-based study". Chest. 143 (5): 1235–1242. doi:10.1378/chest.12-2112. PMID 23139140.
  2. Gando S, Saitoh D, Ogura H, Fujishima S, Mayumi T, Araki T, Ikeda H, Kotani J, Kushimoto S, Miki Y, Shiraishi S, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, Aikawa N (June 2013). "A multicenter, prospective validation study of the Japanese Association for Acute Medicine disseminated intravascular coagulation scoring system in patients with severe sepsis". Crit Care. 17 (3): R111. doi:10.1186/cc12783. PMC 4056654. PMID 23787004.


Template:WS Template:WH